Issued: 11/16/2014
Salix pharmaceuticals, SLXP:
1. Salix pharmaceuticals is now in a ‘Buy‘ position based upon Friday’s strong close (Friday’s close $102.32).
2. A test/attempt at $106/$07 is expected into early next week (week of Nov. 17).
3. Partial long position profits should be taken at/near $104.00, a further portion exited at/near $106.00, and the remainder held for a trend following exit to be messaged in a subsequent update.
4. Once long, a protective sell stop should be placed at $98.60. This stop will be moved higher as the market continues to confirm. Will update.
David Williams
Issued: 11/18/2014
Salix pharmaceuticals, SLXP:
1. We remain long Salix pharmaceuticals based upon Friday’s strong close (Friday’s close/long entry at $102.32).
2. Partial long position profits should be taken at/near $104.00, a further portion exited at/near $106.00, and the remainder held for a trend following exit to be messaged in a subsequent update.
3. Salix remains firm but may not be acting as well as it could.
4. Our protective stop has been raised and $99.80. This stop will continue to be moved higher as the market continues to confirm.
David Williams
Issued: 11/18/2014
Salix pharmaceuticals, SLXP:
1. Exit an initial portion of your long position in Salix pharmaceuticals at current prices (current price $103.07).
2. Our protective sell stop is been raised to $100.50. This stop will continue to be moved higher as the market continues to confirm.
David Williams
Issued: 11/18/2014
Salix pharmaceuticals, SLXP:
1. Today (Tuesday, Nov. 18) Salix pharmaceuticals completed the forecast advance from $102.32 (directed long entry) to our final long position profit target at $106/$07, expected to complete early during this week (week of Nov. 17). Today’s session high, was $106.10.
2. It is assumed that the majority of long positions from $102.30 were exited at/near $106.00. Any remaining long positions can be held for the possibility of higher prices. Will update.
3. Our protective stop has been raised $102.48. This stop will continue to be moved higher as the market continues to confirm.
David Williams
Issued: 11/19/2014
Salix pharmaceuticals, SLXP:
1. Those holding any remaining long positions in Salix should raise their protective sell stop now to $103.40. This stop will continue to be moved higher as the market continues to confirm.
2. Final long position exit should be taken at/near $107.00 as noted in the original forecast.
David Williams
Issued: 11/19/2014
Salix pharmaceuticals, SLXP:
1. Today (Wed., Nov. 19) Salix pharmaceuticals completed the forecast $107.00 final upside target noted in previous updates (today’s session high $106.95).
2. Traders holding any remaining long positions exited at/near $107.00, completing the trade. Will message any further entry or indication in Salix pharmaceutical.
David Williams